Shares of Doximity, Inc. plummeted 25.40% in premarket and early intraday trading on Thursday. The sharp decline followed the company's release of its fiscal fourth-quarter financial results, which revealed an earnings miss and weaker-than-expected revenue guidance for the upcoming periods.

The telehealth company reported adjusted earnings per share of $0.26 for the quarter, missing the analyst consensus estimate of $0.28. Profit was pressured by a substantial increase in operating expenses, which rose to $101.1 million from $75.1 million a year earlier. While quarterly revenue of $145.4 million slightly exceeded expectations, investor sentiment was severely impacted by the company's outlook.

Doximity issued revenue guidance for the first quarter between $151 million and $152 million, below estimates of approximately $153.8 million. More significantly, the company forecast full fiscal year 2027 revenue in the range of $664 million to $676 million, well below the consensus estimate of about $697.4 million. This weak outlook prompted multiple analyst actions, including downgrades and price target cuts from firms such as Wells Fargo, Baird, KeyBanc, and Mizuho, further weighing on the stock.